Hou DY - Search Results

1

OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance.

Hou DY, Xiao WY, Wang JQ, Yaseen M, Wang ZJ, Fei Y, Wang MD, Wang L, Wang H, Shi X, Cai MM, Feng HT, Xu W, Li LL. Hou DY, et al. Biomaterials. 2022 May;284:121523. doi: 10.1016/j.biomaterials.2022.121523. Epub 2022 Apr 12. Biomaterials. 2022. PMID: 35462306

2

Addressable Peptide Self-Assembly on the Cancer Cell Membrane for Sensitizing Chemotherapy of Renal Cell Carcinoma.

Wang Z, An HW, Hou D, Wang M, Zeng X, Zheng R, Wang L, Wang K, Wang H, Xu W. Wang Z, et al. Adv Mater. 2019 Mar;31(11):e1807175. doi: 10.1002/adma.201807175. Epub 2019 Jan 21. Adv Mater. 2019. PMID: 30663139

3

CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.

Wang L, Yang G, Zhao D, Wang J, Bai Y, Peng Q, Wang H, Fang R, Chen G, Wang Z, Wang K, Li G, Yang Y, Wang Z, Guo P, Peng L, Hou D, Xu W. Wang L, et al. Mol Cancer. 2019 Apr 11;18(1):86. doi: 10.1186/s12943-019-0997-z. Mol Cancer. 2019. PMID: 30975145 Free PMC article.

4

Endogenous Reactive Oxygen Species-Triggered Morphology Transformation for Enhanced Cooperative Interaction with Mitochondria.

Cheng DB, Zhang XH, Gao YJ, Ji L, Hou D, Wang Z, Xu W, Qiao ZY, Wang H. Cheng DB, et al. J Am Chem Soc. 2019 May 8;141(18):7235-7239. doi: 10.1021/jacs.8b07727. Epub 2019 Apr 26. J Am Chem Soc. 2019. PMID: 31010287

5

A tumour-selective cascade activatable self-detained system for drug delivery and cancer imaging.

An HW, Li LL, Wang Y, Wang Z, Hou D, Lin YX, Qiao SL, Wang MD, Yang C, Cong Y, Ma Y, Zhao XX, Cai Q, Chen WT, Lu CQ, Xu W, Wang H, Zhao Y. An HW, et al. Nat Commun. 2019 Oct 24;10(1):4861. doi: 10.1038/s41467-019-12848-5. Nat Commun. 2019. PMID: 31649241 Free PMC article.

6

A Near-Infrared Peptide Probe with Tumor-Specific Excretion-Retarded Effect for Image-Guided Surgery of Renal Cell Carcinoma.

An HW, Hou D, Zheng R, Wang MD, Zeng XZ, Xiao WY, Yan TD, Wang JQ, Zhao CH, Cheng LM, Zhang JM, Wang L, Wang ZQ, Wang H, Xu W. An HW, et al. ACS Nano. 2020 Jan 28;14(1):927-936. doi: 10.1021/acsnano.9b08209. Epub 2020 Jan 17. ACS Nano. 2020. PMID: 31927974

7

Click Reaction-Assisted Peptide Immune Checkpoint Blockade for Solid Tumor Treatment.

Xiao WY, Wang Y, An HW, Hou D, Mamuti M, Wang MD, Wang J, Xu W, Hu L, Wang H. Xiao WY, et al. ACS Appl Mater Interfaces. 2020 Sep 9;12(36):40042-40051. doi: 10.1021/acsami.0c10166. Epub 2020 Aug 26. ACS Appl Mater Interfaces. 2020. PMID: 32805827

8

Transformable Dual-Inhibition System Effectively Suppresses Renal Cancer Metastasis through Blocking Endothelial Cells and Cancer Stem Cells.

Wang L, Lv Y, Li C, Yang G, Fu B, Peng Q, Jian L, Hou D, Wang J, Zhao C, Yang P, Zhang K, Wang L, Wang Z, Wang H, Xu W. Wang L, et al. Small. 2020 Oct;16(40):e2004548. doi: 10.1002/smll.202004548. Epub 2020 Sep 3. Small. 2020. PMID: 32881381

9

Correction to: CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.

Wang L, Yang G, Zhao D, Wang J, Bai Y, Peng Q, Wang H, Fang R, Chen G, Wang Z, Wang K, Li G, Yang Y, Wang Z, Guo P, Peng L, Hou D, Xu W. Wang L, et al. Mol Cancer. 2020 Sep 24;19(1):144. doi: 10.1186/s12943-020-01261-y. Mol Cancer. 2020. PMID: 32972401 Free PMC article.

10

An antibody-like peptidic network for anti-angiogenesis.

Zhang K, Zhang H, Zou XR, Hu Y, Hou DY, Fan JQ, Yang C, Chen ZM, Wen SF, Cao H, Yang PP, Wang L. Zhang K, et al. Among authors: hou dy. Biomaterials. 2021 Aug;275:120900. doi: 10.1016/j.biomaterials.2021.120900. Epub 2021 May 18. Biomaterials. 2021. PMID: 34051670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters